JFK Communications
JFK Communications Inc. is a privately held, U.S.-based boutique public relations agency providing strategic communications services to life science, healthcare, and medical technology organizations, with a specialty in oncology. It serves enterprise pharmaceutical, biotech, diagnostic, and medical device clients through retained PR mandates.
- Company typePrivate
- Founded2004
- HeadquartersPrinceton, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What JFK Communications does
JFK Communications Inc. is a U.S.-incorporated, privately held boutique public relations agency headquartered in St. Augustine, Florida, that provides strategic communications services to life science, healthcare, and medical technology organizations. It positions itself with deep specialty in oncology alongside broader therapeutic area coverage spanning cardiology, metabolic disorders, neurology, infectious diseases/virology, respiratory, dermatology, orthopedics, and rheumatology. Services are delivered through a direct, consultative sales model and include Product Public Relations, Media Relations, Advocacy Relations, Data Communications, Media Training, Issues Management, Digital & Social Media Strategy, and Inbound Marketing. The firm operates without institutional funding and is led by founder-CEO John F. Kouten, with a small named team of principals and senior advisors.
The firm monetizes through project-based and retainer professional services engagements with enterprise pharmaceutical, biotech, diagnostic, and medical device clients, with named accounts spanning Novartis Oncology, GE Healthcare Medical Diagnostics, Prometheus Laboratories, Taiho Oncology, Teva Oncology, and Caris Life Sciences. Long-tenured agency-of-record mandates (Prometheus since 2009; Caris exceeding five years; multi-product Novartis programs such as Zometa and Exjade/Asunra) indicate recurring, relationship-driven revenue. Within Digital & Social Media Strategy the firm offers JFK SENTINEL, its in-house social media listening and analytics tool, as a proprietary component used in client work. No public pricing tiers or contract values are disclosed.
Customer segments are organized primarily by vertical: large global life science companies, start-up and mid-stage life science firms, oncology-focused organizations, and patient advocacy groups. Distribution is direct to enterprise buyers through proposals, business development, and industry referrals; the firm supplements this with content marketing on its company blog (covering FDA compliance, ASCO congress, AI in pharma, and sector trends) to support top-of-funnel demand. Geographic reach is described as global via multinational accounts, though physically the operation is single-site in Florida.
JFK Communications firmographics
Firmographics- Name
- JFK Communications
- Legal name
- JFK Communications Inc.
- Website
- https://jfkhealth.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- JFK Communications Inc. is a privately held, U.S.-based boutique public relations agency providing strategic communications services to life science, healthcare, and medical technology organizations, with a specialty in oncology. It serves enterprise pharmaceutical, biotech, diagnostic, and medical device clients through retained PR mandates.
- Ownership category
- akta.pro rank
JFK Communications industry classification
Industry- Product category
- Healthcare Communications and Public Relations
- NAICS
- Public Relations Agencies (54182), Advertising, Public Relations, and Related Services (5418)
- SIC
- Communications Services, Nec (4899)
- akta.pro primary industry
- Healthcare & Life Sciences PR (BPAFADAJ)
- akta.pro secondary industries
- Healthcare & Life Sciences PR (MPAAADAD), Media Relations & Press Office Services (BPAFADAF)
Keywords
Where JFK Communications is headquartered
LocationHeadquarters
- HQ city
- Princeton
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
JFK Communications business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Strategic Communications Services: JFK Communications generates revenue through providing strategic communications solutions including PR, media relations, advocacy relations, data communications, media training, issues management, digital/social media strategy, and inbound marketing services. Revenue appears to be project-based or retainer fee arrangements with life science, healthcare, and medical technology clients.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
JFK Communications product offering
Product offeringCore offering
JFK Communications is a boutique public relations agency providing strategic communications services to life science, healthcare, and medical technology organizations. Its core offering covers product public relations, media relations, advocacy relations, data communications, media training, issues/crisis management, digital and social media strategy, and inbound marketing. The firm specializes in oncology and other complex therapeutic areas, delivering regulatory milestone communications, product launch PR, KOL development, and patient advocacy programs to pharmaceutical, biotech, diagnostic, and medical device clients.
Product overview
JFK Communications is a boutique public relations agency specializing in strategic communications for the life science, healthcare, and medical technology industries. The company offers a comprehensive suite of PR services including Product Public Relations, Media Relations, Advocacy Relations, Data Communications, Media Training, Issues Management, Digital & Social Media Strategy, and Inbound Marketing. As a services company, JFK Communications does not offer software products but rather provides expert consulting and execution across communications disciplines. Notable client work includes supporting GE Healthcare Medical Diagnostics, Novartis Oncology, Teva Oncology, Prometheus Laboratories (Proleukin brand), Taiho Oncology (S-1/Teysuno), and Caris Life Sciences with various PR and communications programs.
Differentiator
Problem solved
Functional benefit
Products and services
- Product Public Relations Core PR service supporting pharmaceutical, diagnostic, and medical device product launches across therapeutic areas including oncology, cardiology, metabolic disorders, neurology, infectious diseases, respiratory diseases, dermatology, orthopedics, and rheumatology. Aimed at life science companies launching or maintaining products in regulated markets.
- Media Relations Media relations services including key message development, spokesperson preparation, media training, media auditing, media monitoring, media list development, expert media pitching, and earned media measurement and reporting for life science, healthcare, and medical technology clients.
- Advocacy Relations Patient advocacy services including educational webinars, live events, peer-to-peer blogs, physician-bylined articles, educational videos, and resources to build partnerships between life science companies and patient advocacy organizations.
- Data Communications Expert guidance on regulatory milestones and events including IND applications, clinical trial launches, FDA filings (NDA, aNDA, OTC, BLA, 510K, PMA), advisory committees, regulatory clearances, expanded access programs, and compliance violations, for life science and medical technology clients.
- Media Training Media training services including message and Q&A development, one-on-one and group media training, on-site or virtual training via GoToMeeting or Skype, mock interviews, simulations, and videotaping of mock interviews for life science executives and spokespersons.
- Issues Management Crisis communications and issues management for pharmaceutical, diagnostic, and medical device companies covering product safety, manufacturing, facility crises, compliance, patent support, pricing issues, clinical trial matters, corporate ethics, and regulatory compliance.
- Digital & Social Media Strategy Strategic digital and social media solutions including website development, SEO and analytics, mobile apps, social media listening via the proprietary JFK SENTINEL tool, branded and unbranded social media plans, social media content, editorial calendars, and content sharing for life science clients.
- Inbound Marketing Inbound marketing services including buyer persona research, content development strategy, website development, social media strategy, blog calendar development and management, web video, email campaigns, and social media monitoring for life science, healthcare, and medical technology clients.
Quantifiable outcome
- Long-term client relationships (e.g., Prometheus Laboratories partnership since 2009, Caris Life Sciences partnership exceeding five years)
- +1 more outcomes
Companies that use JFK Communications
Customer profileNamed customers7 records
Segments5 records
Ideal customer profiles3 records
JFK Communications technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
JFK Communications partnerships and signals
Strategic signalScale indicators2 records
Recent moves4 records
Expansion highlights6 records
JFK Communications competitors and assessment
Company assessmentDirect peers
- GCI Health: Specialist healthcare PR agency serving pharma, biotech, and consumer health clients. Comparable in therapeutic communications, advocacy relations, and oncology work to JFK.
- Canale Communications: Boutique life sciences PR firm serving biotech and pharma clients with integrated communications. Mirrors JFK's boutique-oncology positioning and service mix.
- Spectrum Science: Boutique healthcare and life sciences communications agency with similar oncology and biotech focus. Closest direct peer to JFK in size, service mix, and target customer profile.
- Russo Partners: Specialist life sciences and healthcare PR agency with analogous focus on biotech, pharma, and medical technology clients. Close competitor in oncology and emerging therapy communications.
- LaVoieHealthScience (LaVoie Strategic Communications): Specialist health and science communications firm serving biotech and pharma clients across product PR, advocacy, and investor relations. Direct comparable in niche life science PR positioning.
Broad incumbents
- Syneos Health Communications: Large CRO and communications group offering integrated public relations, medical affairs, and commercialization services to life sciences. Competes with JFK for global pharma communications mandates.
- Real Chemistry (formerly W2O Group): Large data-driven healthcare communications firm offering PR, marketing, and analytics to life sciences. Directly comparable to JFK as a healthcare PR peer but operates at vastly greater scale and breadth.
- FleishmanHillard (Healthcare): Large global public relations firm with a dedicated healthcare and life sciences practice offering the full PR service suite. Often competes with JFK for global pharma and biotech accounts at greater scale.
- Evoke (Evoke Group): Global healthcare agency network offering integrated communications, marketing, and medical affairs. Overlaps with JFK's life science PR scope but at broader portfolio and global scale.
Emerging players
- Biosector 2: Specialty healthcare PR and communications shop focused on biotech and pharma storytelling. Comparable boutique scale and life science positioning, though more recently founded than JFK.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
JFK Communications social profiles
Digital presenceJFK Communications financial estimates
Financial estimateRevenue estimate
Valuation estimate
JFK Communications leadership team
Management profileNumber of profiles
Profiles6 records
JFK Communications funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
JFK Communications M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about JFK Communications
What does JFK Communications do?
JFK Communications is a boutique public relations agency providing strategic communications services to life science, healthcare, and medical technology organizations. Its core offering covers product public relations, media relations, advocacy relations, data communications, media training, issues/crisis management, digital and social media strategy, and inbound marketing. The firm specializes in oncology and other complex therapeutic areas, delivering regulatory milestone communications, product launch PR, KOL development, and patient advocacy programs to pharmaceutical, biotech, diagnostic, and medical device clients.
Is JFK Communications a public or private company?
JFK Communications is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was JFK Communications founded?
JFK Communications was founded in 2004. It employs 1 to 10 people.
Where is JFK Communications based?
JFK Communications is headquartered in Princeton, United States, in the North America region.
How does JFK Communications make money?
One revenue line is on record: strategic Communications Services.
Who are JFK Communications's main competitors?
Direct peers on record are GCI Health, Canale Communications, Spectrum Science, Russo Partners and LaVoieHealthScience (LaVoie Strategic Communications). Broad incumbents are Syneos Health Communications, Real Chemistry (formerly W2O Group), FleishmanHillard (Healthcare) and Evoke (Evoke Group). Biosector 2 is listed as an emerging player.
Does JFK Communications have an API?
No public API is recorded for JFK Communications.
What industry is JFK Communications in?
JFK Communications's product category is Healthcare Communications and Public Relations. Its primary akta.pro industry code is BPAFADAJ, Healthcare & Life Sciences PR, with a secondary code of MPAAADAD, Healthcare & Life Sciences PR. Its NAICS code is 54182 and its SIC code is 4899.